Insider Transactions in Q1 2025 at Azenta, Inc. (AZTA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2025
|
Quentin Koffey Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+44.52%
|
-
|
|
Feb 07
2025
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+19.33%
|
$210,080
$52.32 P/Share
|
|
Feb 07
2025
|
Dipal Doshi |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+50.0%
|
$210,080
$52.32 P/Share
|
|
Feb 07
2025
|
Tina Susan Nova |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+28.55%
|
$210,080
$52.32 P/Share
|
|
Feb 07
2025
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+10.73%
|
$210,080
$52.32 P/Share
|
|
Feb 07
2025
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
5,168
+26.2%
|
$268,736
$52.32 P/Share
|
|
Feb 07
2025
|
Alan J Malus |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+44.52%
|
$210,080
$52.32 P/Share
|
|
Feb 03
2025
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
317
-3.2%
|
$16,484
$52.97 P/Share
|
|
Jan 31
2025
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Open market or private purchase
|
Direct |
417
+1.47%
|
$18,765
$45.88 P/Share
|